GlassScriptPhysician profile
Christopher Tobin Taylor
NPI 1013911791
$1,162.31
in general payments reported to CMS, 2019-2025
15 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $112 · 2021: $170 · 2022: $95.12 · 2023: $146 · 2024: $93.42 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $231.11 | 2019 | |
| Alcon Vision LLC | $219.26 | 2020-2025 | Luxor |
| Abbvie INC. | $162.37 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $83.18 | 2023-2025 | Infuse, Vyzulta |
| Mallinckrodt Hospital Products INC. | $64.29 | 2021-2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $62.69 | 2019-2021 | |
| Allergan, INC. | $60.12 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $55.80 | 2019-2021 | |
| Rxsight INC | $53.85 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Horizon Therapeutics Plc | $49.05 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $39.57 | 2024 | |
| Aerie Pharmaceuticals, INC. | $31.69 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Kala Pharmaceuticals, INC. | $12.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.